NFKB1 and Cognitive impairment: In addition, EA was shown to have a protective effect on LPS-induced cognitive impairment, potentially through the inhibition of NF-κB and COX-2 pathways and subsequent reduction in oxidative damage, improvement in synaptic plasticity, and restoration of cholinergic function [45].